Crescita Therapeutics Financials

CRRTF Stock  USD 0.39  0.00  0.00%   
We suggest to use Crescita Therapeutics fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Crescita Therapeutics is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate and analyze data for twenty-nine available fundamental indicators for Crescita Therapeutics, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Crescita Therapeutics to be traded at $0.3861 in 90 days.
  
Understanding current and past Crescita Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Crescita Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Crescita Therapeutics' assets may result in an increase in income on the income statement.

Crescita Therapeutics Stock Summary

Crescita Therapeutics competes with Cannara Biotech, Knight Therapeutics, Bionoid Pharma, and HLS Therapeutics. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business Address2805 Place Louis-R
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.crescitatherapeutics.com
Phone905 673 4297
CurrencyUSD - US Dollar

Crescita Therapeutics Key Financial Ratios

There are many critical financial ratios that Crescita Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Crescita Therapeutics reports annually and quarterly.

Crescita Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Crescita Therapeutics's current stock value. Our valuation model uses many indicators to compare Crescita Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Crescita Therapeutics competition to find correlations between indicators driving Crescita Therapeutics's intrinsic value. More Info.
Crescita Therapeutics is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about  0.71  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Crescita Therapeutics is roughly  1.40 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Crescita Therapeutics' earnings, one of the primary drivers of an investment's value.

Crescita Therapeutics Systematic Risk

Crescita Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Crescita Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Crescita Therapeutics correlated with the market. If Beta is less than 0 Crescita Therapeutics generally moves in the opposite direction as compared to the market. If Crescita Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Crescita Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Crescita Therapeutics is generally in the same direction as the market. If Beta > 1 Crescita Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Crescita Therapeutics March 4, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Crescita Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Crescita Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Crescita Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Crescita Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Crescita Therapeutics's daily price indicators and compare them against related drivers.

Complementary Tools for Crescita Pink Sheet analysis

When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency